Nerizza Guerin
View detailed information about Nerizza Guerin, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Pharmaceutical Quality Operations I.
Documents (14)
- WARNING LETTER · American Cleaning Solutions · March 28, 2022
- WARNING LETTER · Sagent Pharmaceuticals, Inc. · November 4, 2021
- WARNING LETTER · DuPont Nutrition USA Inc. · December 15, 2021
- WARNING LETTER · Cangene BioPharma, LLC · February 18, 2022
- UNTITLED LETTER · Valgene Incorporated · July 20, 2022
- UNTITLED LETTER · Healthy Choice Compounding LLC · July 15, 2022
- WARNING LETTER · Shuzy Rock Inc. · February 14, 2022
- WARNING LETTER · Bi-Coastal Pharma International · January 14, 2022
- WARNING LETTER RESPONSE · Wedgewood Village Pharmacy, LLC
- WARNING LETTER · MD Pharmaceutical Supply, LLC · May 9, 2022
- EIR · Renaissance Lakewood, LLC · May 24, 2023
- 483 · Bell-More Labs, Inc. · June 7, 2021
- 483 · Shore Institute For Reproductive Medicine, P.C. · March 5, 2008
- 483 · LNK International, Inc. · July 1, 2021
Related Office
Person Information
Name
Nerizza Guerin
Title
Director of Investigations Branch
Role
Regulatory Personnel
ID: 407df995-bd23-4948-82c2-e3bf8a6659b7
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.